According to Kezar Life Sciences's latest financial reports the company's total assets are $0.22 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $0.29 B | 37.46% |
2021-12-31 | $0.21 B | 43.53% |
2020-12-31 | $0.15 B | 69.63% |
2019-12-31 | $89.51 M | -21.95% |
2018-12-31 | $0.11 B | 111.5% |
2017-12-31 | $54.22 M | 374.63% |
2016-12-31 | $11.42 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.25 B | 13.91% | ๐บ๐ธ USA |